Early Experiences With COVID-19 Testing in Transplantation.
Transplant Direct
; 6(7): e572, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-1794966
ABSTRACT
BACKGROUND:
The early effects of coronavirus disease 2019 (COVID-19) on transplantation are dramatic >75% of kidney and liver programs are either suspended or operating under major restrictions. To resume transplantation, it is important to understand the prevalence of COVID-19 among transplant recipients, donors, and healthcare workers (HCWs) and its associated mortality.METHODS:
To investigate this, we studied severe acute respiratory syndrome coronavirus 2 diagnostic test results among patients with end-stage renal disease or kidney transplants from the Johns Hopkins Health System (n = 235), and screening test results from deceased donors from the Southwest Transplant Alliance Organ Procurement Organization (n = 27), and donors, candidates, and HCWs from the National Kidney Registry and Viracor-Eurofins (n = 253) between February 23 and April 15, 2020.RESULTS:
We found low rates of COVID-19 among donors and HCWs (0%-1%) who were screened, higher rates of diagnostic tests among patients with end-stage renal disease or kidney transplant (17%-20%), and considerable mortality (7%-13%) among those who tested positive.CONCLUSIONS:
These findings suggest the threat of COVID-19 for the transplant population is significant and ongoing data collection and reporting is critical to inform transplant practices during and after the pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Diagnostic study
/
Observational study
/
Qualitative research
Language:
English
Journal:
Transplant Direct
Year:
2020
Document Type:
Article
Affiliation country:
TXD.0000000000001024
Similar
MEDLINE
...
LILACS
LIS